How to sell a pharmacy: preparation, valuation and completion

This guide is for community pharmacy owners planning to sell: a retiring contractor with one shop, a couple selling a pair of branches, or a small group trimming its estate. It covers preparation, valuation, the choice of deal structure and the regulatory steps that set the timetable. Smart Funding Solutions is a broker, not a lender, and our part in a sale is on the buyer's side: we arrange acquisition funding from around £10,000 to £500,000+, with larger facilities available in suitable cases. For how pharmacies borrow more generally, see our pharmacy finance hub.

01Start preparing a year or two ahead

Buyers and their lenders price a pharmacy on what they can verify. Most of the work that raises the price, or keeps a sale from collapsing, happens before anyone is told the business is for sale.

• Make the item trend easy to read. Keep at least two years of monthly NHS items and payment schedules together. If items dipped for a known reason, such as a surgery closing for refurbishment, write it down now.
• Build services income. Consistent delivery of Pharmacy First, the New Medicine Service, hypertension case-finding and seasonal vaccinations shows a buyer income that does not depend on reimbursement margin alone.
• Normalise the accounts. Separate your own drawings, family wages and personal costs from the business, and show what a buyer would pay for pharmacist cover if you currently work every session yourself.
• Fix the lease. A lease with only a few years left can stall a sale at the lender stage; our guide to buying a pharmacy with a short lease explains why, from the buyer's side.
• Tidy compliance. Recent GPhC inspection outcomes, controlled drug registers, standard operating procedures and staff training records will all be asked for in due diligence.

02How pharmacies are valued

Most valuations start from adjusted profit, broadly earnings before interest, tax, depreciation and amortisation after a market cost for the pharmacist and any other owner roles. The multiple applied to that profit moves with the item trend, the location and its dependence on one or two surgeries, the services mix, the lease or freehold position, and the wider market for pharmacies at the time. Older rules of thumb based on a percentage of turnover are still quoted, but buyers' lenders size their loans on profit, so a price that cannot be supported by profit tends to fall at the funding stage.

Stock is normally valued separately on the day of completion by an independent stocktaker and paid on top of the price. If you own the building, it is usually valued separately too, and you can sell it, keep it and grant the buyer a lease, or sell it later. Our page on pharmacy premises finance shows how buyers fund a freehold.

03Share sale or asset sale

Sellers often prefer a share sale because the proceeds come to them directly and may qualify for Business Asset Disposal Relief on capital gains, subject to the conditions and lifetime limit. Buyers sometimes prefer assets to leave history behind. Take tax advice before agreeing heads of terms, because the structure is hard to change once a buyer has instructed lenders. The GPhC's guidance on a pharmacy change of ownership and Community Pharmacy England's notes on the NHS change of ownership process set out the regulatory steps in England.

04Who buys, and why their funding matters to you

Typical buyers are employee or locum pharmacists buying a first shop, independents adding a branch and small groups building scale. Most of them borrow, usually a goodwill-based term loan with their own deposit, and the most common reason for a pharmacy sale to fall through late is a buyer whose funding was never properly tested. Before granting exclusivity, ask how the buyer intends to fund the deal, how much of the price is their own money and whether a lender has reviewed the figures.

You can widen the pool of fundable buyers by agreeing to defer part of the price, explained in our guide to vendor finance and deferred consideration. Selling to the pharmacist who already manages the shop is often the smoothest transfer of all, and is funded in a similar way to a management buyout.

05What your buyer's lenders review

Your price is only as good as the buyer's funding, so it helps to know what their lender will test:

• Item volumes and trend: monthly NHS items over at least two years, and whether any dip has a documented cause.
• Services income: how steady Pharmacy First, the New Medicine Service and other commissioned services are, and how much of the profit depends on reimbursement margin.
• Adjusted profit: earnings after paying for pharmacist cover at market rates, rather than relying on your own unpaid sessions.
• The lease: years remaining, renewal rights and landlord consent to assignment.
• The buyer's stake: the deposit they put in, their experience and whether any of the price is deferred to you.

06Documents for the data room

07The sale process step by step

1. Prepare and value. Gather the figures above and agree a realistic asking price with a specialist adviser.
2. Market confidentially. Buyers sign a confidentiality agreement before seeing the name or figures; viewings happen out of hours.
3. Agree heads of terms. Price, deal structure, stock, any deferred element, exclusivity period and the conditions for completion.
4. Due diligence and funding. The buyer's accountants, solicitors and lender examine the business; you answer questions and supply documents promptly.
5. Regulatory approvals and lease. NHS change of ownership where needed, GPhC registration changes and landlord consent to the lease.
6. Exchange and completion. Stock is counted, funds move through the solicitors and you hand over keys, passwords, supplier accounts and NHS systems access.

08Mistakes that delay or derail a sale

• Telling staff or patients too early, before a buyer is committed
• Letting items or services slip while attention is on the sale
• Leaving lease renewal until a buyer's lender asks about it
• Pricing on a turnover rule of thumb that profit cannot support
• Granting exclusivity to a buyer whose funding is unproven
• Incomplete records that turn due diligence into weeks of queries

09How we help your buyer complete